Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report

Published:2024-01 Issue: Volume:Volume 17 Page:31-39
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Fu Chunlan^ORCID,Zhu Yuanyuan,Huang Weijia,Luo Yi,Hu Yongxian^ORCID,Huang He,Sun Jie

Publisher

Informa UK Limited

Reference23 articles.

1. Special case of a patient in the blast phase of chronic myeloid leukemia successfully treated with tocilizumab during critical SARS-CoV-2 infection

2. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

3. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

4. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

5. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3